Styrbjorn Friman

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. doi Recurrence of disease after liver transplantation
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
    Transplant Proc 45:1178-81. 2013
  2. ncbi Recurrence of hepatitis C after liver transplantation
    S Friman
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Transplant Proc 37:3311-2. 2005
  3. doi Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results
    Styrbjorn Friman
    Transplant Institute, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Gastroenterol 46:370-5. 2011
  4. ncbi Cholangiocarcinoma--current treatment options
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Surg 100:30-4. 2011
  5. doi Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Goteborg, Sweden
    Am J Transplant 11:1444-55. 2011
  6. ncbi Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors
    Michael Olausson
    Sahlgrenska Transplant Institute, Sahlgrenska Academy, University of Goteborg, Goteborg, Sweden
    Liver Transpl 13:327-33. 2007
  7. doi Stable long-term renal function after pediatric liver transplantation
    Gustaf Herlenius
    Transplant Institute, Sahlgrenska University Hospital, Goteborg, Sweden
    Pediatr Transplant 14:409-16. 2010
  8. ncbi Early renal function post-liver transplantation is predictive of progressive chronic kidney disease
    Gustaf Herlenius
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Gastroenterol 43:344-9. 2008
  9. doi Chronic kidney disease--a common and serious complication after intestinal transplantation
    Gustaf Herlenius
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplantation 86:108-13. 2008
  10. doi Sympathetic nerves do not affect experimental ischemia-reperfusion injury of rat liver
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
    Transplant Proc 41:743-5. 2009

Detail Information

Publications48

  1. doi Recurrence of disease after liver transplantation
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
    Transplant Proc 45:1178-81. 2013
    ..This overview reports follow up, diagnosis, and treatment of recurrences...
  2. ncbi Recurrence of hepatitis C after liver transplantation
    S Friman
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Transplant Proc 37:3311-2. 2005
    ..Today there is growing concern as to the prognosis of these patients and how we should treat them. This is an overview of the developments in this field concerning treatment of recurrence and the role of preemptive treatment...
  3. doi Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results
    Styrbjorn Friman
    Transplant Institute, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Gastroenterol 46:370-5. 2011
    ..The aim of this study has been to report our results as well as to explore factors that influence patient survival after liver transplantation for CCA...
  4. ncbi Cholangiocarcinoma--current treatment options
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Surg 100:30-4. 2011
    ..The lack of effective medical treatment makes a radical surgical resection or hepatectomy the only therapeutic option. Most of the CCAs are unresectable at presentation and the prognosis for these patients is dismal...
  5. doi Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Goteborg, Sweden
    Am J Transplant 11:1444-55. 2011
    ..Ongoing studies are evaluating alternative sotrastaurin regimens...
  6. ncbi Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors
    Michael Olausson
    Sahlgrenska Transplant Institute, Sahlgrenska Academy, University of Goteborg, Goteborg, Sweden
    Liver Transpl 13:327-33. 2007
    ..In conclusion, the critical prognosticators for long-term outcome still remain to be defined. The experience with multivisceral transplantation for patients with endocrine tumors of the pancreatic head is still limited...
  7. doi Stable long-term renal function after pediatric liver transplantation
    Gustaf Herlenius
    Transplant Institute, Sahlgrenska University Hospital, Goteborg, Sweden
    Pediatr Transplant 14:409-16. 2010
    ..05). At one, three and five yr post-transplantation there was no longer a statistically significant difference between these cohorts. Our findings suggest that there can be a long-term recovery of renal function after LT in children...
  8. ncbi Early renal function post-liver transplantation is predictive of progressive chronic kidney disease
    Gustaf Herlenius
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Gastroenterol 43:344-9. 2008
    ....
  9. doi Chronic kidney disease--a common and serious complication after intestinal transplantation
    Gustaf Herlenius
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplantation 86:108-13. 2008
    ..We describe long-term renal function after intestinal transplantation by serial measurements of glomerular filtration rates (GFR) with Chromium EDTA clearance...
  10. doi Sympathetic nerves do not affect experimental ischemia-reperfusion injury of rat liver
    S Friman
    Transplant Institute, Sahlgrenska University Hospital, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
    Transplant Proc 41:743-5. 2009
    ..We investigated whether sympathetic, noradrenergic nerves participate in experimental acute ischemia-reperfusion injury of the rat liver...
  11. ncbi [Treatment of patients with liver metastases from colorectal cancer. More patients can benefit from the treatment!]
    Per Lindner
    Verksamhetsområde kirurgi och transplantation, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 100:2684-8. 2003
    ..A surgeon with liver surgery competence should see patients with a presumably resectable cancer...
  12. ncbi [Liver dialysis using MARS in acute hepatic failure. Promising results in a pilot setting]
    Marie Felldin
    Enheten för transplantation och leverkirurgi, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 100:3836-8, 3841. 2003
    ..In these cases the MARS-treatment seemed to have positive effects on the course and outcome of the disease but there are a need for controlled trials to clearly prove the benefit of the treatment...
  13. ncbi Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience
    D J Lukes
    Department of Surgery and Transplantation, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 38:2671-2. 2006
    ..We analyzed causes of late death (>/=2 years post-OLT) in 679 consecutive primary recipients in our institution...
  14. ncbi Retransplantation of the liver
    B I Gustafsson
    Transplantation and Liver Surgery Unit, Department of Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 38:1438-9. 2006
    ..In summary, liver re-TX is a complicated procedure associated with significant mortality and morbidity, but considering that the actual patient group has a poor prognosis without re-TX, the results are nevertheless encouraging...
  15. ncbi Extended right-sided liver resection for colorectal liver metastases--impact of percutaneous portal venous embolisation
    P Lindner
    Department of Surgery and Radiology, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Eur J Surg Oncol 32:292-6. 2006
    ..To compare the outcome after extended right liver lobe resection (ERL) for patients with liver metastases from colorectal cancer with preceding portal vein embolisation (PVE) with a non-PVE-group...
  16. ncbi Nitric oxide-mediated effects on liver blood flow
    B I Gustafsson
    Transplantation and Liver Surgery Unit, Dept of Surgery, Sahlgrenska University Hospital, 413 45 Goteborg, Sweden
    Transplant Proc 37:3338-9. 2005
    ..Upon unclamping, there was no difference in ALT levels, PLBF, or MAP. To conclude, NO displayed a positive tonic effect on liver blood flow, reduction of which with l-NAME did not aggravate mild ischemia/reperfusion injury in this model...
  17. ncbi Pharmacological preconditioning of rat liver by up-regulation of heme oxygenase 1
    J Heiman
    Department of Surgery, Sahlgrenska University Hospital, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden
    Transplant Proc 38:2705-7. 2006
    ....
  18. ncbi Effect of remote preconditioning on mild or severe ischemia-reperfusion injury to rat liver
    B I Gustafsson
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 38:2708-9. 2006
    ....
  19. ncbi [Liver transplantation from a living donor is now possible. The first cases in Sweden completed with good results]
    M Olausson
    Transplantation och leverkirurgi, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 96:452-5. 1999
    ..The technique will improve the outcome of liver transplantation in children, and reduce the risk of death due to long waiting lists...
  20. ncbi Interventional treatment of gastrointestinal neuroendocrine tumours
    H Ahlman
    Department of Surgery, Radiology and Pathology at the Lundberg Laboratory for Cancer Research, Sahlgrenska University Hospital, Goteborg University, Sweden
    Digestion 62:59-68. 2000
    ..Such studies are hampered by the lack of strict surgical programs running over long periods and the relative rarity of NE tumours. Liver transplantation may be another treatment modality in selected cases...
  21. ncbi Liver transplantation for polycystic liver disease--indications and outcome
    B I Gustafsson
    Transplantation and Liver Surgery Unit, Department of Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 35:813-4. 2003
  22. ncbi The liver protective effect of ischemic preconditioning may be mediated by adenosine
    B Nilsson
    Department of Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transpl Int 13:S558-61. 2000
    ..This effect was abolished by pretreatment with 8-PT. Adenosine appears to be a crucial effector in IPC. Clinical studies need to be undertaken to explore a possible effect of IPC in liver transplantation...
  23. ncbi Treatment with the molecular adsorbent recirculating system in patients with acute liver failure
    M Felldin
    Transplantation and Liver Surgery Unit, Goteborg, Sweden
    Transplant Proc 35:822-3. 2003
  24. ncbi Liver transplantation for metastatic neuroendocrine tumor disease
    C Cahlin
    Transplantation and Liver Surgery Unit, Department of Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 35:809-10. 2003
  25. doi Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations
    Martin Lagging
    Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, Goteborg
    Scand J Infect Dis 41:389-402. 2009
    ..For liver transplant patients pre-emptive therapy is not recommended; hence, treatment should be deferred until histological recurrence...
  26. ncbi Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis
    M Castedal
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Transplant Proc 37:3313-4. 2005
    ..We present our results of preemptive treatment with pegylated interferon and ribavirin after liver transplantation for hepatitis C cirrhosis...
  27. ncbi Preconditioning protects against ischemia/reperfusion injury of the liver
    B Nilsson
    Department of Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    J Gastrointest Surg 4:44-9. 2000
    ..In our experimental model of ischemia/reperfusion injury in the rat liver, we found an equally beneficial effect with ischemic and pharmacologic preconditioning. Adenosine appears to be a crucial factor in IPC...
  28. ncbi Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation
    M Castedal
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 35:820-1. 2003
  29. ncbi Adult ABO-incompatible liver transplantation, using A and B donors
    Ulrika Skogsberg
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Xenotransplantation 13:154-9. 2006
    ..This applies in both urgent situations and for elective patients. We report on our experience with ABO-incompatible liver transplantation using A2 and B non-secretor donors here...
  30. ncbi Survival after liver transplantation for cholangiocarcinoma has increased during the last decade
    P Lindner
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 35:811-2. 2003
  31. ncbi Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004
    A Floden
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
    Transplant Proc 39:385-6. 2007
    ..We analyzed the gender, age, and MELD score associated with different indications for OLT during this period...
  32. ncbi Liver transplantation for treatment of metastatic neuroendocrine tumors
    Hakan Ahlman
    Department of Surgery and Department of Pathology, Goteborg University, Sahlgrenska University Hospital, Goteborg, Sweden
    Ann N Y Acad Sci 1014:265-9. 2004
    ..The experience with multivisceral transplantation is still limited...
  33. ncbi Auxiliary liver and combined kidney transplantation prevents hyperacute kidney rejection in highly sensitized patients
    M Olausson
    Department of Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 34:3106-7. 2002
  34. ncbi Pseudoaneurysm of the hepatic artery following liver transplantation
    J Fistouris
    Department of Transplantation and Liver Surgery Sahlgrenska University Hospital, Gothenburg, Sweden
    Transplant Proc 38:2679-82. 2006
    ....
  35. ncbi Successful ABO-incompatible liver transplantation using A2 donors
    U Skogsberg
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 38:2667-70. 2006
    ..We herein have reported our experience with ABO-incompatible liver transplantation using A(2) donors to blood group O recipients...
  36. ncbi The cadaveric organ donor program at Sahlgrenska University Hospital, 1977 to 2005
    C Lovén
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 38:2631-2. 2006
    ..9 organs per donor. These results may be explained by improved organ donor care and organization, and by increased awareness of potential donors among elderly patients...
  37. ncbi Outcome of renal transplantation subsequent to liver, heart, or lung transplantation
    H Tarnow
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 38:2649-50. 2006
    ..The outcome of renal transplantation subsequent to liver, heart, or lung transplantation is good with satisfactory renal function in this study population...
  38. ncbi Conversion to sirolimus after kidney and liver transplantation: indications and outcomes
    L Wramner
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
    Transplant Proc 35:791. 2003
  39. ncbi Acetazolamide inhibits stimulated feline liver and gallbladder bicarbonate secretion
    B Nilsson
    Department of Surgery, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Acta Physiol Scand 174:117-23. 2002
    ..The presence of CA II in the gallbladder was demonstrated by immunoblotting. Biliary CA activity has an important function in the regulation of VIP- and secretin-stimulated bicarbonate secretion across the gallbladder mucosa...
  40. ncbi Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients
    M Olausson
    Department of Transplantation and Liver Surgery, Sahlgrenska Universith Hospital, Goteborg, Sweden
    Am J Transplant 7:130-6. 2007
    ....
  41. ncbi MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004
    A Floden
    Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
    Transplant Proc 38:2673-4. 2006
    ..Patients with acute hepatic failure had the highest MELD scores while patients undergoing OLT because of malignancy had the lowest MELD score. MELD score seemed to be a useful tool for retrospective analyzes of potential OLT recipients...
  42. ncbi Initial experience with multivisceral, cluster, and combined liver and small bowel transplantation in Sweden
    G Herlenius
    Department of Liver and Transplant Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
    Transplant Proc 34:865. 2002
  43. ncbi Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab
    S Westphal
    Department of Pediatrics, The Queen Silvia Children s Hospital, Goteborg, Sweden
    Transplant Proc 38:2659-60. 2006
    ..Successful treatment included a combination of plasma exchanges, rituximab, immunoglobulin, and antithymocyte globulin...
  44. ncbi [Liver transplantation--from experiment to routine care. Experiences from the first 500 liver transplantations in Gothenburg]
    M Olausson
    ,
    Lakartidningen 98:4556-62, 4564. 2001
    ..This article also describes our experience of in situ splitting and living-related liver transplantation as well as other innovations such as cavoportal hemitransposition and multivisceral transplantation...
  45. ncbi Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
    B Brandsaeter
    Dept of Medicine, Rikshospitalet, Oslo, Norway
    Scand J Gastroenterol 38:1176-83. 2003
    ..Because these patients are difficult to evaluate with regard to timing of liver transplantation, it is important to establish predictors of post-transplant survival...
  46. ncbi Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
    M Leidenius
    Transplantation and Liver Surgery, Helsinki University Hospital, Finland
    J Hepatol 34:792-8. 2001
    ..0005). CONCLUSIONS: The relatively short duration of PSC and the absence of varices in patients with BDC suggest that BDC, unlike HCC, is not necessarily a late complication of end-stage PSC, as was previously assumed...
  47. ncbi Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation
    K Bjøro
    Department of Medicine, Rikshospitalet, Oslo, Norway
    Transplantation 75:347-53. 2003
    ..Survival after liver transplantation for fulminant hepatic failure has been reported to be less favorable than survival for patients with chronic liver diseases...
  48. ncbi Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation
    F Vincenti
    Kidney Transplant Service, UCSF, San Francisco, California 94143, USA
    Transplant Proc 37:1001-4. 2005
    ..At 3 months, median GFR (Nankivell) was 63.7 mL/min; median serum creatinine was 137 micromol/L. Full complete results are expected in December 2005...